Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting of claudin-4 by Clostridium perfringens enterotoxin-conjugated polysialic acid nanoparticles for pancreatic cancer therapy
Man Kyu Shim, Jinhee Na, In Kyung Cho, et al.
Journal of Controlled Release (2021) Vol. 331, pp. 434-442
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Emerging Albumin-Binding Anticancer Drugs for Tumor-Targeted Drug Delivery: Current Understandings and Clinical Translation
Hanhee Cho, Seong Ik Jeon, Cheol‐Hee Ahn, et al.
Pharmaceutics (2022) Vol. 14, Iss. 4, pp. 728-728
Open Access | Times Cited: 73
Claudin-4: A New Molecular Target for Epithelial Cancer Therapy
Rina Fujiwara‐Tani, Shiori Mori, Ruiko Ogata, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5494-5494
Open Access | Times Cited: 28
The role and mechanism of claudins in cancer
Dewen Wang, Weihan Zhang, Galiullin Danil, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 38
Novel EPR-enhanced strategies for targeted drug delivery in pancreatic cancer: An update
Vahideh Mohammadzadeh, Niloufar Rahiman, Seyedeh Maryam Hosseinikhah, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 73, pp. 103459-103459
Closed Access | Times Cited: 30
Structural and biophysical insights into targeting of claudin-4 by a synthetic antibody fragment
Satchal K. Erramilli, Pawel K. Dominik, Chinemerem P. Ogbu, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 6
Acquired and intrinsic gemcitabine resistance in pancreatic cancer therapy: Environmental factors, molecular profile and drug/nanotherapeutic approaches
Milad Ashrafizadeh, Kuo Luo, Wei Zhang, et al.
Environmental Research (2023) Vol. 240, pp. 117443-117443
Closed Access | Times Cited: 15
Rediscovery of nanoparticle-based therapeutics: boosting immunogenic cell death for potential application in cancer immunotherapy
Suah Yang, In‐Cheol Sun, Hee Sook Hwang, et al.
Journal of Materials Chemistry B (2021) Vol. 9, Iss. 19, pp. 3983-4001
Closed Access | Times Cited: 32
The bacterial thiopeptide thiostrepton. An update of its mode of action, pharmacological properties and applications
Christian Bailly
European Journal of Pharmacology (2021) Vol. 914, pp. 174661-174661
Closed Access | Times Cited: 31
In vivo toxicity evaluation of tumor targeted glycol chitosan nanoparticles in healthy mice: repeated high-dose of glycol chitosan nanoparticles potentially induce cardiotoxicity
Hyeyoun Chang, Ji Young Yhee, Sangmin Jeon, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 11
Living Therapeutics: Precision Diagnosis and Therapy with Engineered Bacteria
Ruyan Xie, Duoyang Fan, Cheng Xiang, et al.
Biomaterials (2025) Vol. 321, pp. 123342-123342
Closed Access
Do Bacteria Provide an Alternative to Cancer Treatment and What Role Does Lactic Acid Bacteria Play?
Leon M. T. Dicks, Wian Vermeulen
Microorganisms (2022) Vol. 10, Iss. 9, pp. 1733-1733
Open Access | Times Cited: 18
Disruption of Claudin-Made Tight Junction Barriers by Clostridium perfringens Enterotoxin: Insights from Structural Biology
Chinemerem P. Ogbu, Sourav Roy, Alex J. Vecchio
Cells (2022) Vol. 11, Iss. 5, pp. 903-903
Open Access | Times Cited: 17
Cryo-EM structures of Clostridium perfringens enterotoxin bound to its human receptor, claudin-4
Sewwandi S. Rathnayake, Satchal K. Erramilli, Anthony A. Kossiakoff, et al.
Structure (2024) Vol. 32, Iss. 11, pp. 1936-1951.e5
Open Access | Times Cited: 3
Claudins as diagnostic tools and therapeutic targets—Glimpse of the horizon
Keiji Sugiyama, Ian Chau
Cancer Treatment Reviews (2025) Vol. 133, pp. 102888-102888
Open Access
Nonviral siRNA delivery systems for pancreatic cancer therapy
Shahin Aghamiri, Pourya Raee, Sam Talaei, et al.
Biotechnology and Bioengineering (2021) Vol. 118, Iss. 10, pp. 3669-3690
Open Access | Times Cited: 17
Nano-sized drug delivery systems to potentiate the immune checkpoint blockade therapy
Man Kyu Shim, Su Kyung Song, Seong Ik Jeon, et al.
Expert Opinion on Drug Delivery (2022) Vol. 19, Iss. 6, pp. 641-652
Closed Access | Times Cited: 10
Liposomes targeting the cancer cell-exposed receptor, claudin-4, for pancreatic cancer chemotherapy
Chaeeun Bang, Min Gyu Park, In Kyung Cho, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 6
Application of C-Terminal Clostridium Perfringens Enterotoxin in Treatment of Brain Metastasis from Breast Cancer
Amita R. Banga, Peace Odiase, Kartik Rachakonda, et al.
Cancers (2022) Vol. 14, Iss. 17, pp. 4309-4309
Open Access | Times Cited: 9
Tumor-Specific Monomethyl Auristatin E (MMAE) Prodrug Nanoparticles for Safe and Effective Chemotherapy
Hanhee Cho, Man Kyu Shim, Yujeong Moon, et al.
Pharmaceutics (2022) Vol. 14, Iss. 10, pp. 2131-2131
Open Access | Times Cited: 9
Zeolitic Imidazole Framework-90-Based Pesticide Smart-Delivery System with Enhanced Antimicrobial Performance
You Liang, Sijin Wang, Hongqiang Dong, et al.
Nanomaterials (2022) Vol. 12, Iss. 20, pp. 3622-3622
Open Access | Times Cited: 7
Mesenchymal Stem Cell-Mediated Deep Tumor Delivery of Gold Nanorod for Photothermal Therapy
Wan Su Yun, Man Kyu Shim, Seungho Lim, et al.
Nanomaterials (2022) Vol. 12, Iss. 19, pp. 3410-3410
Open Access | Times Cited: 6
Cryo-EM structures of a synthetic antibody against 22 kDa claudin-4 reveal its complex withClostridium perfringensenterotoxin
Satchal K. Erramilli, Pawel K. Dominik, Chinemerem P. Ogbu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Responsive Nanomaterial Delivery Systems for Pancreatic Cancer Management
Amr Elsherbeny, Hulya Bayraktutan, Umut Can Öz, et al.
Advanced Therapeutics (2023) Vol. 7, Iss. 3
Open Access | Times Cited: 3
Expression and Targeted Application of Claudins Family in Hepatobiliary and Pancreatic Diseases
Fangqian Du, Yuwei Xie, Shengze Wu, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 1801-1821
Open Access
Tight Junctions and Cancer: Targeting Claudin-1 and Claudin-4 in Thyroid Pathologies
Jędrzej Borowczak, Dariusz Łaszczych, Katarzyna Olejnik, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1304-1304
Open Access
Page 1 - Next Page

Scroll to top